Hajdu-Cheney syndrome: a review
- PMID: 25491639
- PMCID: PMC4269900
- DOI: 10.1186/s13023-014-0200-y
Hajdu-Cheney syndrome: a review
Abstract
Hajdu Cheney Syndrome (HCS), Orpha 955, is a rare disease characterized by acroosteolysis, severe osteoporosis, short stature, specific craniofacial features, wormian bones, neurological symptoms, cardiovascular defects and polycystic kidneys. HCS is rare and is inherited as autosomal dominant although many sporadic cases have been reported. HCS is associated with mutations in exon 34 of NOTCH2 upstream the PEST domain that lead to the creation of a truncated and stable NOTCH2 protein with enhanced NOTCH2 signaling activity. Although the number of cases with NOTCH2 mutations reported are limited, it would seem that the diagnosis of HCS can be established by sequence analysis of exon 34 of NOTCH2. Notch receptors are single-pass transmembrane proteins that determine cell fate, and play a critical role in skeletal development and homeostasis. Dysregulation of Notch signaling is associated with skeletal developmental disorders. There is limited information about the mechanisms of the bone loss and acroosteolysis in HCS making decisions regarding therapeutic intervention difficult. Bone antiresorptive and anabolic agents have been tried to treat the osteoporosis, but their benefit has not been established. In conclusion, Notch regulates skeletal development and bone remodeling, and gain-of-function mutations of NOTCH2 are associated with HCS.
Figures


Similar articles
-
Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations.Curr Osteoporos Rep. 2016 Aug;14(4):126-31. doi: 10.1007/s11914-016-0311-6. Curr Osteoporos Rep. 2016. PMID: 27241678 Free PMC article. Review.
-
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab.Bone. 2016 Nov;92:150-156. doi: 10.1016/j.bone.2016.08.025. Epub 2016 Aug 31. Bone. 2016. PMID: 27592446 Free PMC article.
-
Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders.Metabolism. 2018 Mar;80:48-56. doi: 10.1016/j.metabol.2017.08.002. Epub 2017 Aug 24. Metabolism. 2018. PMID: 28941602 Free PMC article. Review.
-
NOTCH2 Hajdu-Cheney Mutations Escape SCFFBW7-Dependent Proteolysis to Promote Osteoporosis.Mol Cell. 2017 Nov 16;68(4):645-658.e5. doi: 10.1016/j.molcel.2017.10.018. Mol Cell. 2017. PMID: 29149593 Free PMC article.
-
High Bone Turnover in Mice Carrying a Pathogenic Notch2 Mutation Causing Hajdu-Cheney Syndrome.J Bone Miner Res. 2018 Jan;33(1):70-83. doi: 10.1002/jbmr.3283. Epub 2017 Sep 20. J Bone Miner Res. 2018. PMID: 28856714
Cited by
-
The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor α.J Biol Chem. 2019 Sep 27;294(39):14203-14214. doi: 10.1074/jbc.RA119.009824. Epub 2019 Aug 1. J Biol Chem. 2019. PMID: 31371452 Free PMC article.
-
Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations.Curr Osteoporos Rep. 2016 Aug;14(4):126-31. doi: 10.1007/s11914-016-0311-6. Curr Osteoporos Rep. 2016. PMID: 27241678 Free PMC article. Review.
-
Induction of the Hajdu-Cheney Syndrome Mutation in CD19 B Cells in Mice Alters B-Cell Allocation but Not Skeletal Homeostasis.Am J Pathol. 2018 Jun;188(6):1430-1446. doi: 10.1016/j.ajpath.2018.02.010. Epub 2018 Mar 12. Am J Pathol. 2018. PMID: 29545197 Free PMC article.
-
Hajdu Cheney syndrome; A novel NOTCH2 mutation in a Syrian child, and treatment with zolidronic acid: A case report and a literature review of treatments.Ann Med Surg (Lond). 2021 Nov 3;71:103023. doi: 10.1016/j.amsu.2021.103023. eCollection 2021 Nov. Ann Med Surg (Lond). 2021. PMID: 34840770 Free PMC article.
-
Severe Acro-osteolysis Mimicking Arthritis Mutilans in a Patient with Primary Hyperparathyroidism: A Case Report.Curr Rheumatol Rev. 2024;20(5):574-585. doi: 10.2174/0115733971273126231214063403. Curr Rheumatol Rev. 2024. PMID: 38314597
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous